Inhalation Sciences Sweden AB (publ) releases Q1 Report 2021
(Stockholm, Sweden, 19 May, 2021) Inhalation Sciences AB announces that the company's Q1 Report for 2021 (in Swedish) is now available on the company's website.Summary of the interim report · ISAB has submitted a Clinical Trial Application with PreciseInhale® to the Medical Products Agency. · The company has received an expanded internationally registered trademark for PreciseInhale®. Revenue for the first quarter of 2021 landed at just over 2 800 000 SEK, with, among other things, two PreciseInhale® systems being delivered to two new customers, the University of Vienna and